| Dossier: | Ctd |
|---|---|
| Transport Package: | Free |
| Specification: | 25mg |
| Trademark: | Sinolead |
| Origin: | China |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
| Generic Name | Diclofenac Sodium Suppositories 25mg |
| Strength | 25mg |
| Packing | 10suppositories/box |
| Origin | China |
This product is white or light yellow plug.
Anti-inflammatory and analgesic drugs. For rheumatoid arthritis, pain after surgery and fever due to various causes.
When the suppository is taken out, after wetting with a small amount of warm water, gently plug into the anus 2cm, adults 1 capsule at a time, 1-2 times a day or follow the doctor's advice.
Matters needing attention:
Avoid combination with other NSaids, including selective COX-2 inhibitors.
According to the need to control symptoms, the use of the lowest effective dose for the shortest duration of treatment can minimize adverse reactions.
Adverse effects of gastrointestinal bleeding, ulcers and perforation can occur at any time during treatment with all NSaids, and the risk can be fatal. These adverse events may or may not be accompanied by warning symptoms, and regardless of whether the patient has a history of gastrointestinal adverse events or serious gastrointestinal events. Patients with a history of gastrointestinal disease (ulcerative colitis, Crohn's disease) should use NSaids with caution to avoid exacerbating their condition. When patients take this drug and develop gastrointestinal bleeding or ulcers, the drug should be discontinued. The increased frequency of adverse reactions to the use of NSaids in older patients, especially gastrointestinal bleeding and perforation, can be fatal.
Clinical trials of multiple COX-2 selective and non-selective NSAIDs with a duration of up to 3 years have shown that this product may be associated with an increased risk of serious cardiovascular thrombotic adverse events, myocardial infarction and stroke, which can be fatal. All NSAIDs, including COX-2 selective or non-selective drugs, may have similar risks. Patients with cardiovascular disease or risk factors for cardiovascular disease are at greater risk. Even if there are no prior cardiovascular symptoms, doctors and patients should be alert to the occurrence of such events. Patients should be informed of the symptoms and/or signs of serious cardiovascular safety and the steps to take if they occur. Patients should be alert to signs and symptoms such as chest pain, shortness of breath, weakness, and slurred speech, and should seek medical help as soon as any of these signs or symptoms occur.
Like all non-steroidal anti-inflammatory drugs (NSAIDs), it can cause new hypertension or worsen existing hypertension symptoms, either of which can lead to an increased rate of cardiovascular events. When patients taking thiazines or loop diuretics take non-steroidal anti-inflammatory drugs (NSAIDs), the effectiveness of these drugs may be affected. Non-steroidal anti-inflammatory drugs (NSAIDs), including this product, should be used with caution in patients with hypertension. Blood pressure should be monitored closely at the beginning of treatment and throughout the course of treatment.
It should be used with caution in patients with a history of hypertension and/or heart failure, such as fluid retention and edema.
NSAIDs, including this product, may cause fatal, severe skin adverse reactions, such as exfoliative dermatitis, Stevens Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN). These serious events can occur without warning. Patients should be advised of the signs and symptoms of a severe skin reaction and should discontinue the product at the first appearance of a skin rash or other signs of an allergic reaction.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}